P2X7 Receptor–Mediated Inflammation in Cardiovascular Disease

J Zhou, Z Zhou, X Liu, HY Yin, Y Tang… - Frontiers in …, 2021 - frontiersin.org
Purinergic P2X7 receptor, a nonselective cation channel, is highly expressed in immune
cells as well as cardiac smooth muscle cells and endothelial cells. Its activation exhibits to …

P2X7 receptors: an untapped target for the management of cardiovascular disease

BG Shokoples, P Paradis… - … , Thrombosis, and Vascular …, 2021 - Am Heart Assoc
Chronic low-grade inflammation contributes to the development of several diseases,
including cardiovascular disease. Adequate strategies to target inflammation in …

P2X7 receptor in cardiovascular disease: The heart side

C Guerra Martinez - Clinical and Experimental Pharmacology …, 2019 - Wiley Online Library
The P2X7 receptor is a ligand‐gated purinergic receptor activated by extracellular ATP. The
receptor is highly expressed in immune cells and in the brain, and, upon activation, the …

P2X7 receptor and heart function in a mouse model of systemic inflammation due to high fat diet

F Raggi, C Rossi, F Faita, M Distaso… - Journal of …, 2022 - Taylor & Francis
Purpose Low-grade inflammation contributes to heart failure in obesity or type 2 diabetes
mellitus. The P2X7 receptor (P2X7R) is a key regulator of several pro-inflammatory …

The P2X7 receptor in inflammatory diseases: angel or demon?

LEB Savio, P de Andrade Mello… - Frontiers in …, 2018 - frontiersin.org
Under physiological conditions, adenosine triphosphate (ATP) is present at low levels in the
extracellular milieu, being massively released by stressed or dying cells. Once outside the …

Structure-activity relationships and therapeutic potential of purinergic P2X7 receptor antagonists

I Ghafir El Idrissi, S Podlewska, C Abate… - Current medicinal …, 2024 - ingentaconnect.com
The purinergic P2X7 receptor (P2X7R), an ATP-gated non-selective cation channel, has
emerged as a gatekeeper of inflammation that controls the release of proinflammatory …

P2X7 receptor: a potential therapeutic target for autoimmune diseases

F Cao, LQ Hu, SR Yao, Y Hu, DG Wang, YG Fan… - Autoimmunity …, 2019 - Elsevier
Abstract P2X7 receptor (P2X7R), a distinct ligand-gated ion channel, is a member of
purinergic type 2 receptor family with ubiquitous expression in human body. Previous …

P2X7 receptor orchestrates multiple signalling pathways triggering inflammation, autophagy and metabolic/trophic responses

E Orioli, E De Marchi, A Lisa Giuliani… - Current medicinal …, 2017 - ingentaconnect.com
P2X7 receptor is an ion channel activated by extracellular adenosine trisphosphate (eATP)
that attracted increasing attention for its role in immune reactions, neurobiology and …

P2X7 Receptors in Neurological and Cardiovascular Disorders

SD Skaper, P Debetto, P Giusti - Cardiovascular psychiatry and …, 2009 - Wiley Online Library
P2X receptors are ATP‐gated cation channels that mediate fast excitatory transmission in
diverse regions of the brain and spinal cord. Several P2X receptor subtypes, including …

The P2X7 purinergic receptor: an emerging therapeutic target in cardiovascular diseases

Z Chen, L He, L Li, L Chen - Clinica Chimica Acta, 2018 - Elsevier
The P2X7 purinergic receptor, a calcium permeable cationic channel, is activated by
extracellular ATP. Most studies show that P2X7 receptor plays an important role in the …